Engineering

Education

Business Development

Administrative

Accounting

Operations

Information Technology

Research

Human Resources

Quality Assurance

Healthcare Services

Finance

Program and Project Management

Entrepreneurship

CEO & Co-founder

New AI research reshapes neuroprotective drug discovery funding

Great Oaks Venture Capital Portfolio

Verge Genomics Completes Initial Financing to Discover and Develop Treatments for Neurodegenerative Diseases Using Genomic Data

Verge Genomics Seeded with $4M

Computational Biologist

Verge Genomics is transforming drug discovery by leveraging artificial intelligence and human data to address high clinical failure rates. The Computational Biologist will work closely with the platform and computational biology teams to define and enable new product offerings, develop predictive models, and lead high-impact projects in translational biology.